Literature DB >> 26706294

Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis.

Amber M Patterson1, Andrea E Bonny2, William E Shiels2, Elizabeth A Erwin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26706294     DOI： 10.1016/j.anai.2015.11.010

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  13 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 2.  Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta-analysis.

Authors:  Nor Rahimah Aini; Norhayati Mohd Noor; Mohd Khairi Md Daud; Sarah K Wise; Baharudin Abdullah
Journal:  Clin Transl Allergy       Date:  2021-08-17       Impact factor: 5.871

Review 3.  Modified Allergens for Immunotherapy.

Authors:  Pattraporn Satitsuksanoa; Anna Głobińska; Kirstin Jansen; Willem van de Veen; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

4.  Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial.

Authors:  Hye Jung Park; Sae-Hoon Kim; Yoo Seob Shin; Chul Hwan Park; Eun-Suk Cho; Seung Joon Choi; So Hyun Park; Joo Hyun Jung; Il Gyu Kang; Myoung Seok Lee; Dae Woo Kim; Sang Min Lee; Min-Suk Yang; Sang Pyo Lee
Journal:  Respir Res       Date:  2021-06-04

5.  A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies.

Authors:  Sang Pyo Lee; Seung Joon Choi; Eugene Joe; Sang Min Lee; Min Woo Lee; Jung Woo Shim; Yu Jin Kim; Sun Young Kyung; Jeong Woong Park; Sung Hwan Jeong; Joo Hyun Jung
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

6.  A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy.

Authors:  Dan Weinfeld; Ulla Westin; Laila Hellkvist; Ulf-Henrik Mellqvist; Ingvar Jacobsson; Lars-Olaf Cardell
Journal:  Allergy Asthma Clin Immunol       Date:  2020-04-28       Impact factor: 3.406

7.  Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.

Authors:  Terese Hylander; Olivia Larsson; Ulla Petersson-Westin; Mia Eriksson; Susanna Kumlien Georén; Ola Winqvist; Lars-Olaf Cardell
Journal:  Respir Res       Date:  2016-01-27

Review 8.  Allergen-specific intralymphatic immunotherapy in human and animal studies.

Authors:  Seon Tae Kim; So Hyun Park; Sang Min Lee; Sang Pyo Lee
Journal:  Asia Pac Allergy       Date:  2017-07-19

9.  Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.

Authors:  Beatriz Tavira; Hugo Barcenilla; Jeannette Wahlberg; Peter Achenbach; Johnny Ludvigsson; Rosaura Casas
Journal:  J Diabetes Res       Date:  2018-05-24       Impact factor: 4.011

Review 10.  The future outlook on allergen immunotherapy in children: 2018 and beyond.

Authors:  Stefania Arasi; Giovanni Corsello; Alberto Villani; Giovanni Battista Pajno
Journal:  Ital J Pediatr       Date:  2018-07-11       Impact factor: 2.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.